Clarification of the Billing of Immunosuppressive Drugs
Physician Practice Insider, September 18, 2017
On September 1, CMS published MLN Matters 10235 to supplement CMS Medicare Claims Processing Transmittal 3856, which updates the manual to remove a double negative statement in order to provide clear instruction on the billing of immunosuppressive drugs. The transmittal was also published September 1.
Effective date: October 2, 2017
Implementation dates: October 2, 2017
Related Products
Most Popular
- Articles
-
- Don't forget the three checks in medication administration
- Five ways to safeguard your patients' valuables
- Note similarities and differences between HCPCS, CPT® codes
- The consequences of an incomplete medical record
- Q&A: Primary, principal, and secondary diagnoses
- Skills of effective case managers
- OB services: Coding inside and outside of the package
- Nursing responsibilities for managing pain
- Practice the six rights of medication administration
- Reimbursement for Facility and Professional Services in a Provider-Based Department by Gina M. Reese, Esq., RN
- E-mailed
-
- Plan of Care Supports Documentation of Homebound Status
- Q/A: Coding infusions to correct low potassium levels
- Note from the instructor: CMS clarifies billing guidelines on proper billing for drugs in a single-dose or single-use vial, including billing for discarded drugs
- Neurological checks for head injuries
- Modifiers and medical necessity
- HIPAA Q&A: Cameras in patient rooms
- Follow these tips to properly report bladder catheter codes
- Examine cardboard boxes stored on floor to avoid infection control, life safety citations
- Differentiate between types of wound debridement
- Consider two options for coding Rho(D) immune globulin given in pregnancy
- Searched